Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2015 call → NOWe need to determine if management conveys that successive engagements of the same kind are coming in at progressively larger size. The question asks: does management describe that the company's deals, orders, contracts, projects, customers, sites, or programs are individually bigger, broader, or longer than before for the same offering? We need to look for a comparison against the company's own recent past, that it's already real and recurring, and that it's early. Let's scan the transcript for any statements about deal size escalation. Victor Coleman mentions various leasing activities. For example, he talks about Netflix pre-leasing ICON: initially 200,000 sq ft, then later they executed a lease for the remaining 123,000 sq ft. That's a single tenant expanding, but is that a pattern? He says "our Netflix deal remains the largest release ever signed in Hollywood in terms of square feet." That's a record, but is it framed as part of an upward drift? He doesn't explicitly say that deals are getting bigger overall. He mentions other leases but not necessarily that they are larger than before. He also mentions "we executed 1.6 million square feet of leases and cash rent spreads north of 30%" for the year, but that's volume and rent spreads, not necessarily unit size. He talks about "over 860,000 square feet executed and in leases and another 745,000 square feet in LOI" - that's total volume, not individual deal size. He mentions "we're in leases with a well-regarded non-tech tenant for over half of our now fully in total 450 Alaska Way development project" - that's a large lease, but again, is it part of a pattern? He also says "we have over 860,000 square feet executed and in leases" - that's total. The question is specifically about the size of individual engagements escalating. Management does not seem to explicitly compare the average size of new leases to historical averages. They talk about strong demand, but not that each new deal is bigger than the last. There is a mention of "the largest release ever signed in Hollywood" for Netflix, but that's a single event.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.